Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease

Introduction: Proteinuria is a major risk factor for the progression of chronic kidney disease (CKD). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) demonstrated a nephroprotective and antiproteinuric effect in people with type 2 diabetes (T2DM) and proteinuric CKD. We conducted a retrospective...

Description complète

Détails bibliographiques

Auteurs principaux:	Irene Capelli, Danilo Ribichini, Michele Provenzano, Daniele Vetrano, Valeria Aiello, Giuseppe Cianciolo, Valentina Vicennati, Alessandro Tomassetti, Ginevra Moschione, Sabrina Berti, Uberto Pagotto, Gaetano La Manna
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-04-01
Collection:	Life
Sujets:	sodium-glucose cotransporter 2 SGLT2 inhibitors proteinuria diabetes chronic kidney disease diabetic kidney disease
Accès en ligne:	https://www.mdpi.com/2075-1729/13/4/1061
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!